Cargando…

New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets

Infections of Candida spp. etiology are frequently treated with azole drugs. Among azoles, the most widely used in the clinical scenario remains fluconazole (FLC). Promising results in treatment of dangerous, systemic Candida infections demonstrate the advantages of combined therapies carried out wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brankiewicz, Wioletta, Okońska, Joanna, Serbakowska, Katarzyna, Lica, Jan, Drab, Marek, Ptaszyńska, Natalia, Łęgowska, Anna, Rolka, Krzysztof, Szweda, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026428/ https://www.ncbi.nlm.nih.gov/pubmed/35456526 http://dx.doi.org/10.3390/pharmaceutics14040693

Ejemplares similares

Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
por: Ptaszyńska, Natalia, et al.
Publicado: (2020)

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
por: Glavaš, Mladena, et al.
Publicado: (2022)

Can Immobilized Artificial Membrane Chromatography Support the Characterization of Antimicrobial Peptide Origin Derivatives?
por: Ciura, Krzesimir, et al.
Publicado: (2021)

Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry
por: Gitlin-Domagalska, Agata, et al.
Publicado: (2023)

Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells
por: Lica, Jan Jakub, et al.
Publicado: (2021)

Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy
por: Hawryłkiewicz, Aleksandra, et al.
Publicado: (2021)

Inhibition of Human and Yeast 20S Proteasome by Analogues of Trypsin Inhibitor SFTI-1
por: Dębowski, Dawid, et al.
Publicado: (2014)

Cancer immune escape: the role of antigen presentation machinery
por: Kallingal, Anoop, et al.
Publicado: (2023)

Modulation of ERG gene expression in fluconazole-resistant human and animal isolates of Trichophyton verrucosum
por: Gnat, Sebastian, et al.
Publicado: (2021)

Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response
por: Mieszała, Małgorzata, et al.
Publicado: (2019)

Development of Safirinium dyes for new applications: fluorescent staining of bacteria, human kidney cells, and the horny layer of the epidermis
por: Fedorowicz, Joanna, et al.
Publicado: (2022)

Three-Dimensional Urethral Profilometry—A Global Urethral Pressure Assessment Method
por: Szepieniec, Wioletta Katarzyna, et al.
Publicado: (2021)

Fluconazole (Diflucan®)
por: Hollier, Lisa M., et al.
Publicado: (1995)

Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of Cryptococcus deuterogattii
por: Bertout, Sébastien, et al.
Publicado: (2023)

Synergic Effect of Phthalide Lactones and Fluconazole and Its New Analogues as a Factor Limiting the Use of Azole Drugs against Candidiasis
por: Krężel, Piotr, et al.
Publicado: (2022)

Fluconazole conjugated-gold nanorods as an antifungal nanomedicine with low cytotoxicity against human dermal fibroblasts
por: Hamad, Khawla M., et al.
Publicado: (2020)

The relationship between the use of fluconazole & the incidence of fluconazole-resistant Candida species
por: Kuo, Chia-Chang, et al.
Publicado: (2014)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Synergistic Effects of Propolis Combined with 2-Phenoxyethanol and Antipyretics on the Growth of Staphylococcus aureus
por: Grecka, Katarzyna, et al.
Publicado: (2021)

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012)

The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
por: Li, Liping, et al.
Publicado: (2019)

In-Vitro Activity of Nano Fluconazole and Conventional Fluconazole against Clinically Important Dermatophytes
por: MUSAVI BAFRUI, Najmossadat, et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes:A Clinical Update of Safety and Efficacy
por: Drab, Scott R.
Publicado: (2016)

Relationship between Telomere Length, TERT Genetic Variability and TERT, TP53, SP1, MYC Gene Co-Expression in the Clinicopathological Profile of Breast Cancer
por: Dratwa, Marta, et al.
Publicado: (2022)

Coffea canephora Peptides in Combinatorial Treatment with Fluconazole: Antimicrobial Activity against Phytopathogenic Fungus
por: Bard, Gabriela C. V., et al.
Publicado: (2018)

A pilot study on ultrashort peptide with fluconazole: A promising novel anticandidal combination
por: Darwish, Rula M., et al.
Publicado: (2023)

Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
por: Nouraei, S., et al.
Publicado: (2017)

Potential of Methylglyoxal-Conjugated Chitosan Nanoparticles in Treatment of Fluconazole-Resistant Candida albicans Infection in a Murine Model
por: Khan, Shaheer Hasan, et al.
Publicado: (2020)

Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis
por: Ter-Avetisyan, Gohar, et al.
Publicado: (2009)

Fluconazole in the treatment of Cushing's disease
por: Burns, Kharis, et al.
Publicado: (2016)

Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant Candida albicans and Candida glabrata biofilms
por: Panariello, Beatriz Helena Dias, et al.
Publicado: (2018)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of Talaromyces marneffei
por: Kai-su, Pan, et al.
Publicado: (2022)

Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and Non-albicans Candida Species
por: Locke, Jeffrey B., et al.
Publicado: (2018)

Targeting the Expanded TCF4/Fuchs’ Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates
por: Hu, Jiaxin, et al.
Publicado: (2023)

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans
por: Bhattacharya, Somanon, et al.
Publicado: (2021)

Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015)

Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020)

2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Fluconazole Induced Fixed Drug Eruption
por: Kim, Chi Yeon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bmg7791153kjqcsnhubj3i07b6